Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway-Reference-Cited by-同舟云学术

Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway

Published:2018-03-23 Issue:22 Volume:9 Page:16074-16086
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Adimonye Anthony¹,Stankiewicz Elzbieta¹,Kudahetti Sakunthala¹,Trevisan Giorgia²,Tinwell Brendan³,Corbishley Cathy³,Lu Yong-Jie¹,Watkin Nick⁴,Berney Daniel¹

Affiliation:

1. Centre for Molecular Oncology, Bart’s Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

2. Department of Histopathology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom

3. Department of Cellular Pathology, St George’s Hospital, London, United Kingdom

4. Department of Urology, St George’s Hospital, London, United Kingdom

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-37 attenuated HPV induced inflammation of oral epithelial cells via inhibiting PI3K/AKT/mTOR;2024-09-10

2. Increased HRD score in cisplatin resistant penile cancer cells;BMC Cancer;2022-12-23

3. RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer;Journal of Oncology;2022-04-19

4. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review;International Journal of Molecular Sciences;2021-12-27

5. miR‑130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways;Experimental and Therapeutic Medicine;2021-12-01